This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Apr 7;369(9568):1146-7.

doi: 10.1016/S0140-6736(07)60540-6.

More evidence to favour newborn screening for cystic fibrosis

Bridget Wilcken¹, Kevin Gaskin

Affiliations

PMID: 17416243
DOI: 10.1016/S0140-6736(07)60540-6

Comment

More evidence to favour newborn screening for cystic fibrosis

Bridget Wilcken et al. Lancet. 2007.

. 2007 Apr 7;369(9568):1146-7.

doi: 10.1016/S0140-6736(07)60540-6.

Authors

Bridget Wilcken¹, Kevin Gaskin

Affiliation

¹ Children's Hospital at Westmead, NSW 2145, and University of Sydney, Sydney, NSW 2006, Australia. bridgetw@chw.edu.au

PMID: 17416243
DOI: 10.1016/S0140-6736(07)60540-6

No abstract available

PubMed Disclaimer

Comment on

Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study.
Sims EJ, Mugford M, Clark A, Aitken D, McCormick J, Mehta G, Mehta A; UK Cystic Fibrosis Database Steering Committee. Sims EJ, et al. Lancet. 2007 Apr 7;369(9568):1187-95. doi: 10.1016/S0140-6736(07)60565-0. Lancet. 2007. PMID: 17416263

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- Genetic Alliance
- MedlinePlus Health Information